At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (Short Title (HOP-3)
In Brief
A Phase 2 clinical trial evaluating Acyline, placebo hCG (no active ingredient), and 2 other interventions for Healthy Males. Completed, enrolled 59 participants across 1 site.
Detailed Summary
The purpose of this investigational study is to determine how much male hormone, testosterone, is necessary to maintain sperm production in the testis. This knowledge will be used to help in the development of a safe male hormonal contraception.
Study Details
Timeline
Interventions
300 ug/kg subcutaneous injections on Day 1.
placebo hCG
15 IU subcutaneous injection every other day for 10 days (5 doses)
60 IU subcutaneous injection
125 IU subcutaneous injection
75 mg testosterone gel applied transdermally for 10 days